Natural products to drugs: natural product-derived compounds in clinical trials

被引:625
作者
Butler, Mark S. [1 ,2 ]
机构
[1] MerLion Pharmaceut, Singapore 117528, Singapore
[2] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore
关键词
D O I
10.1039/b514294f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Natural product and natural product-derived compounds that are being evaluated in clinical trials or are in registration (as at 31st December 2007) have been reviewed, as well as natural product-derived compounds for which clinical trials have been halted or discontinued since 2005. Also discussed are natural product-derived drugs launched since 2005, new natural product templates and late-stage development candidates.
引用
收藏
页码:475 / 516
页数:42
相关论文
共 632 条
[1]  
Abou-Gharbia M, 2002, BIODIVERSITY: BIOMOLECULAR ASPECTS OF BIODIVERSITY AND INNOVATIVE UTILIZATION, P63
[2]  
*ADV LIF SCI, 2006, FORM 10 Q
[3]  
Advani R, 2003, CLIN CANCER RES, V9, P5187
[4]  
Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1
[5]   Appetite suppression and weight reduction by a centrally active aminosterol [J].
Ahima, RS ;
Patel, HR ;
Takahashi, N ;
Qi, Y ;
Hileman, SM ;
Zasloff, MA .
DIABETES, 2002, 51 (07) :2099-2104
[6]   Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-κB-regulated gene products [J].
Ahn, Kwang Seok ;
Sethi, Gautam ;
Chao, Ta-Hsiang ;
Neuteboom, Saskia T. C. ;
Chaturvedi, Madan M. ;
Palladino, Michael A. ;
Younes, Anas ;
Aggarwal, Bharat B. .
BLOOD, 2007, 110 (07) :2286-2295
[7]   TOTAL SYNTHESIS OF HALICHONDRIN-B AND NORHALICHONDRIN-B [J].
AICHER, TD ;
BUSZEK, KR ;
FANG, FG ;
FORSYTH, CJ ;
JUNG, SH ;
KISHI, Y ;
MATELICH, MC ;
SCOLA, PM ;
SPERO, DM ;
YOON, SK .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (08) :3162-3164
[8]   Pharmacological properties of the ubiquitous natural product betulin [J].
Alakurtti, Sami ;
Makela, Taru ;
Koskimies, Salme ;
Yli-Kauhaluoma, J. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 29 (01) :1-13
[9]   Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications [J].
Alarcn de la Lastral, C. ;
Villegas, I. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 :1156-1160
[10]   Molecular mechanisms of antibacterial multidrug resistance [J].
Alekshun, Michael N. ;
Levy, Stuart B. .
CELL, 2007, 128 (06) :1037-1050